RazorResources

Navigate the Future of Pharmacy Benefits with Ease

Categories
TL;DR 67 Healthcare Leaders Were Asked One Question. Here’s the Condensed Take.
Variations in Prescription Drug Costs: Cutting Through the Chaos with RazorMetrics
GLP-1s Going Direct, How Novo and Lilly’s DTC Strategy is Changing the Game for Patients and Plan Sponsors
Beware the Hidden Risks of Dietary Supplements
From Promise to Practice: Addressing RTBT Shortcomings with RazorMetrics
Protect Medicaid While Reducing Waste with Cutting-edge Cost Containment
2025’s Fiduciary Pressures: How Employers Can Stay Ahead of Legal Risks
Chronic Disease Cost of Unaffordable Prescriptions
GLP-1s in 2025: High Demand, High Cost, Low Accessibility